Preparation method and application of novel FISH probe for detecting HER2 gene amplification
By using the oligo probe preparation method, repeating sequences are removed and oligonucleotide fragments are chemically synthesized using molecular bioinformatics, and fluorescent in situ hybridization probes for HER2 gene amplification are prepared. This solves the problems of high probe preparation cost and low detection efficiency in existing technologies, and achieves rapid and accurate detection with high specificity and low background.
Patent Information
- Application Number
- CN202411130929.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-08-18
- Filing Date
- 2024-08-16
- Publication Date
- 2024-11-15
AI Technical Summary
Existing HER2 gene detection methods suffer from problems such as high probe preparation costs, high hybridization background, strong non-specific signals, and low detection efficiency due to uneven probe size. Furthermore, artificially synthesized probes are expensive and have long supply cycles, which affects clinical applications.
Using the oligo probe preparation method, repetitive sequences were removed through molecular bioinformatics, and oligonucleotide fragments of consistent length were designed and chemically synthesized. An oligonucleotide library was constructed, and PCR amplification and fluorescent labeling were performed to prepare a fluorescent in situ hybridization probe for detecting HER2 gene amplification.
The prepared probes have high specificity, clear signals, and low background, which reduces production costs, improves detection accuracy and efficiency, and are suitable for large-scale production. In addition, the probe size is controllable, and the penetration ability is strong, making them suitable for rapid and accurate diagnosis.
Smart Images

Figure CN118957070A_ABST
Abstract
Description
[0001] This application claims priority to the prior Chinese application, application number: 2023110455106, filing date August 18, 2023; all contents thereof are made part of the present invention. Technical Field
[0002] The invention belongs to the field of medical detection, and specifically relates to a preparation method and application of a novel FISH probe for detecting HER2 gene amplification. Technical Background
[0003] Among breast cancer patients, approximately 20%-30% of patients have HER2 gene overexpression due to HER2 gene amplification, among which the incidence of HER2 gene overexpression is relatively high. HER2 gene overexpression induces human breast tumors, and related studies have shown that breast cancer patients with HER2 gene overexpression have a poor prognosis. Therefore, the detection of HER2 gene expression levels has become an important means to assess the prognosis of breast cancer patients. Since the spread and overexpression of HER2 gene are related to the prognosis of breast cancer and have a guiding role in clinical treatment, the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) recommend that all breast cancer patients should have their HER2 gene status tested. At present, the detection technology for HER2 gene status in breast cancer can be roughly divided into the following levels:
[0004] 1) Detection of HER2 gene DNA level, such as fluorescence in situ hybridization (FISH), bright field in situ hybridization (BISH), etc.;
[0005] 2) Detection of HER2 transcription levels, such as RNA in situ hybridization (RNA-ISH).
[0006] 3) Detection of HER2 protein levels, such as immunohistochemistry (IHC);
[0007] The FDA-certified detection methods are mainly IFC and FISH. A brief introduction to the two detection methods is as follows:
[0008] 1. FISH: Fluorescence in situ hybridization, a method of physical mapping, is a method of using probes labeled with fluorescent substances to target specific nucleotide fragments - probes, based on the principles of denaturation, renaturation, and double-strand complementation to display sequence positions on cell nucleus chromosomes. This technology is fast, safe, highly sensitive, and the probes can be stored for a long time. It is one of the technical methods for clinical molecular pathology diagnosis and has been widely used in cytogenetics, tumor biology, prenatal diagnosis and other fields.
[0009] The clinical testing criteria for HER2 gene are:
[0010] Positive: gene copy number>6.0, FISH ratio>2.2;
[0011] Suspicious: gene copy number 4.0-6.0, FISH ratio 1.8-2.2;
[0012] Negative: gene copy number <4.0, FISH ratio <1.8.
[0013] 2. IHC: Immunohistochemistry, the principle of which is the interaction between antigens and antibodies. Antigen substances are detected with the help of a microscope to observe the distribution of macromolecules such as proteins and peptides in cells. The clinical IHC detection standards are:
[0014] Positive: The entire cell membrane is stained, the staining is complete and the color is bright, and more than 10% of the cancer cell membranes are strongly positive;
[0015] Suspicious: incomplete staining, mild staining, ≤10% of cancer cell membranes show strong positivity;
[0016] Negative: Incomplete or fuzzy staining, more than 10% of the cancer cell membranes show strong positive results; or there is no staining in the entire cell membrane, or the staining is incomplete, and ≤10% of the cancer cell membranes show strong positive results.
[0017] In addition, other new detection methods have also made progress. BISH is a new technology for HER2 gene detection that has emerged in the past decade, mainly including chromogenic in situ hybridization (CISH) and silver-enhanced in situ hybridization (SISH). In October 2013, ASCO / CAP released the guidelines for HER2 gene detection in breast cancer, listing BISH as a new technology for HER2 gene detection in breast cancer. In 2000, Tanner first reported the feasibility of using CISH to detect HER2 gene amplification. Studies have shown that CISH and FISH have strong consistency, which can make up for the instability of IHC test results. Subsequently, a large number of studies have confirmed that the test results of CISH and FISH are highly consistent (85% to 100%), and they have good reproducibility between laboratories and have a wide range of practical use value. However, although CISH solves the problem of high requirements and high costs of FISH equipment, the main disadvantage of this method is that there is no internal control. When encountering chromosome 17 polysomy or low-level amplification of HER2, accurate conclusions cannot be drawn. It is suitable for use in laboratories without FISH detection conditions. In summary, FISH is more widely used in clinical diagnosis of HER2 gene status in breast cancer.
[0018] In the current domestic market, there are three companies of a certain scale operating and selling fluorescent in situ hybridization clinical diagnostic products, namely Abbott, Jinpujia (GP), and LBP Pharmaceutical Technology Co., Ltd. The former has a more comprehensive product range, but Abbott's labeling kit has more noise in the internal control CEN17 in clinical applications. CEN17 is a centromere probe that targets the centromere region of chromosome 17 and is composed of a large number of repeated sequences. Therefore, the total number of specific sequences is relatively small, and it is often used to determine the number of HER2; the latter two have relatively fewer product types and are more expensive.
[0019] At present, the traditional FISH probe preparation method is based on the technology of bacterial plasmid or phage recombinant artificial genome (BAC or PAC), first the bacteria or phage containing BAC or PAC are expanded and cultured, and then BAC or PAC is extracted to clone the target sequence, and then this is used as a template, and polymerase gap translation or chain reaction PCR (random primer method) are used to generate unlabeled probes, and the latter is fluorescently labeled, and finally prepared into probes for detection. The probe generated by using gap translation technology with BAC cloning as a template is the mainstream of probe products at home and abroad, and is a first-generation probe. The main disadvantage of this type of probe is that it contains repetitive sequences and non-specific sequences, and repetitive and non-specific sequences are the sources of hybridization background and non-specific signals, and Cot1 DNA rich in human genome repetitive sequences is needed to suppress background and non-specific signals, thereby increasing the probe production cost. At the same time, although the inhibition of Cot1 DNA can greatly reduce the hybridization background, the background is still high, and non-specific signals cannot be completely eliminated. In addition, the sizes of these probes vary, with the length of the probe fragments ranging from 50bp to 1,000bp, and uneven penetration of cells or tissues, resulting in imbalances in hybridization efficiency. Subsequently, the production method of the first-generation probes was improved, that is, BAC was still used as a template, the PCR product was mixed with Cot1 DNA, and then denatured, renatured, treated with double-stranded specific DNA hydrolases, removed repetitive sequences, and fluorescently labeled, and finally a probe without repetitive sequences was obtained. Probes without repetitive sequences reduce the hybridization background, eliminate nonspecific signals, increase the cell penetration of the probe, and improve the hybridization efficiency, which is the second-generation probe. Although the performance of the second-generation probe is better than that of the first generation, since the preparation of both generations of probes uses BAC clones as templates for amplification, and the size and number of BAC clones are fixed and limited, the size is generally around 100-200kb; and the extraction of BAC not only requires large equipment, but is also time-consuming and labor-intensive, resulting in high preparation costs.
[0020] The completion of human genome sequencing and the development of nucleic acid synthesis technology have made it possible to artificially synthesize fluorescent in situ hybridization probes, and the length of artificially synthesized probes is controllable. Using modern bioinformatics to design and produce a new generation of oligonucleotide probes through chemical synthesis, it is completely free from the limitations of BAC cloning. However, the preparation process of this type of probe requires repeated synthesis, resulting in high production costs and long supply cycles, which affects the widespread clinical application. Summary of the invention
[0021] In view of the shortcomings of existing technologies and products and considering the importance of HER2 gene amplification detection probes for medical examinations, the present invention provides a novel in situ hybridization (FISH) probe for detecting HER2 gene amplification and a preparation method thereof. The probe preparation process belongs to an oligo probe preparation method, and the specific steps are as follows: using molecular bioinformatics technology to remove repetitive sequences, and designing and chemically synthesizing oligonucleotide fragments with consistent lengths targeting target fragments, establishing an oligonucleotide library, and then amplifying and fluorescently labeling the oligonucleotide sequences, and finally obtaining a fluorescent in situ hybridization probe for detecting HER2 gene amplification.
[0022] In one aspect, the present invention provides a method for preparing a novel FISH probe for detecting HER2 gene amplification, wherein the preparation method belongs to an oligo probe preparation method and comprises the following steps:
[0023] (1) determining the probe target region of the HER2 gene and the CEN17 locus and removing repeated nucleotide sequences in the probe target region, wherein the HER2 gene probe target region includes the coding region of the HER2 gene and the non-coding regions at the 5' end and the 3' end;
[0024] (2) designing and chemically synthesizing oligonucleotide fragments of uniform length according to the HER2 gene / CEN17 locus probe target region, wherein the oligonucleotide sequence length is 60 to 240 bp; the oligonucleotide fragments comprise a linker and a fragment that specifically binds to the HER2 gene / CEN17 locus probe target region; and the oligonucleotide sequences constitute an oligonucleotide library;
[0025] Chemical synthesis can unify the length of probes, allowing the probes to better enter the test samples and improve hybridization efficiency; the purpose of adding linkers is for subsequent amplification. The presence of linker sequences can amplify all specific nucleotide sequences containing the same linker at one time, without the need to design amplification primers for the probes one-to-one, reducing time and money costs; moreover, if a PCR amplification system contains too many different amplification primers, the amplification efficiency will be reduced.
[0026] (3) Using the oligonucleotide library in step (2) as a template and the linker sequence in step (2) as a primer, PCR amplification is performed to obtain a probe template library; using the probe template library as a template, forward and reverse primers containing fluorescent markers are used to perform PCR amplification to obtain an in situ hybridization fluorescent probe for detecting HER2 gene amplification using CEN17 as an internal control, wherein the forward and reverse primer sequences are the same as the linker sequence.
[0027] The first amplification is to obtain a multi-copy probe template library, and the target concentration can be achieved by adjusting the number of amplifications. The probe template library can be stored and reused; the second amplification is to obtain a single-use fluorescent probe. If the oligonucleotide library is directly amplified with fluorescently labeled primers instead of preparing the probe template library first, the concentration of the obtained fluorescent probe is limited. If the probe concentration is low, the fluorescence observed under a fluorescent microscope is weak, so it is not possible to judge whether the copy number of the HER2 gene has increased, and the effect of detecting lung cancer cannot be achieved; and if the oligonucleotide library is directly amplified, the latter will be greatly damaged, which is not suitable for long-term mass production of probes.
[0028] Furthermore, the linker sequence designed in step (2) and the primers used to amplify the probe template library in step (3) are the forward primer shown in SEQ ID NO:1 and the reverse primer shown in SEQ ID NO:2, the forward primer shown in SEQ ID NO:3 and the reverse primer shown in SEQ ID NO:4, the forward primer shown in SEQ ID NO:5 and the reverse primer shown in SEQ ID NO:6, the forward primer shown in SEQ ID NO:7 and the reverse primer shown in SEQ ID NO:8, the forward primer shown in SEQ ID NO:9 and the reverse primer shown in SEQ ID NO:10, the forward primer shown in SEQ ID NO:11 and the reverse primer shown in SEQ ID NO:12, the forward primer shown in SEQ ID NO:13 and the reverse primer shown in SEQ ID NO:14, the forward primer shown in SEQ ID NO:15 and the reverse primer shown in SEQ ID NO:16, the forward primer shown in SEQ ID NO:17 and the reverse primer shown in SEQ ID NO:18, the forward primer shown in SEQ ID NO:19 and the reverse primer shown in SEQ ID NO:20. The reverse primer shown in SEQ ID NO:20, the forward primer shown in SEQ ID NO:21 and the reverse primer shown in SEQ ID NO:22, the forward primer shown in SEQ ID NO:23 and the reverse primer shown in SEQ ID NO:24, the forward primer shown in SEQ ID NO:25 and the reverse primer shown in SEQ ID NO:26, the forward primer shown in SEQ ID NO:27 and the reverse primer shown in SEQ ID NO:28, the forward primer shown in SEQ ID NO:29 and the reverse primer shown in SEQ ID NO:30, at least one pair of the above 15 primer pairs.
[0029] Preferably, the linker sequence designed in step (2) and the primers used to amplify the probe template library in step (3) are the forward primer shown in SEQ ID NO: 21 and the reverse primer shown in SEQ ID NO: 22.
[0030] The present invention explores the effect of different linker sequences (4 pairs) on the probe binding efficiency and finds that the linker sequence affects the binding efficiency of the probe to the target site. This may be because the linker sequence itself or the linker sequence forms a secondary structure with the sequence that specifically binds to the target region, thereby affecting the spatial binding of the probe to the target region. The probe hybridization efficiency of primer pair 11 consisting of a forward primer shown in SEQ ID NO: 21 and a reverse primer shown in SEQ ID NO: 22 is the highest.
[0031] Furthermore, the target region of the HER2 gene probe in step (1) starts from BV105677 at the 5' end of the HER2 gene and ends at RH75294 at the 3' end of the gene, covering an area of about 400 kb; the CEN17 site includes the centromeric region of human chromosome 17.
[0032] Using bioinformatics methods, 4,277 and 17 specific binding nucleotide fragments (excluding linkers) were designed for the HER2 gene / CEN17 locus probe target region, respectively, with a length of 101 bp.
[0033] Furthermore, the DNA polymerase used in PCR amplification in step (3) is Phanta ax Super-Fidelity DNA Polymerase.
[0034] The present invention uses three different high-fidelity enzymes (KAPA HiFi, TIANSeq HiFi Amplification Mi and Phantaax Super-Fidelity DNA Polymerase) to amplify the probe, and uses FISH experiments to test the final effect of amplification by different enzymes. The experimental results show that the above three enzymes can all be used to amplify FISH probes for detecting the number of HER2 genes, but Phantaax Super-Fidelity DNA Polymerase has the best effect.
[0035] . Further, the repetitive sequence in step (1) comprises oligonucleotide sequences of TTTT and AAAA; and the oligonucleotide sequence in step (2) is 121 bp.
[0036] Furthermore, in step (3), the probe targeting the HER2 gene region is labeled with the green fluorescent dye Fluorescein, while the probe targeting the CEN17 region is labeled with the orange fluorescent dye ATTO-1.
[0037] The present invention explores the detection effect of cross-combination labeling FISH probes between different fluorescent dyes (3 orange dyes and 2 green dyes), and finds that the combination labeling of fluorescent dyes Fluorescein and ATTO-1 has the best effect.
[0038] Furthermore, the concentration ranges of the fluorescent dyes Fluorescein and ATTO-1 are 0.005-0.1 mM and 0.005-0.1 mM, wherein the optimal concentrations are 0.05 mM and 0.01 mM, respectively.
[0039] On the other hand, the present invention provides a novel FISH probe for detecting HER2 gene amplification. The probe is prepared by the above method, and the FISH probe also contains a hybridization solution and a staining solution.
[0040] On the other hand, the present invention provides a use of a specific amplification primer to improve the post-probe fluorescence effect obtained in the preparation of a fluorescent in situ hybridization probe for detecting HER2 gene amplification, wherein the sequence of the specific amplification primer pair is a forward primer shown in SEQ ID NO: 21 and a reverse primer shown in SEQ ID NO: 22.
[0041] On the other hand, the present invention provides a use of an oligo method in the preparation of a fluorescent in situ hybridization probe for detecting HER2 gene amplification to improve the post-target fluorescence effect of the obtained probe.
[0042] The present invention compares the HER2 gene copy number detection probes prepared by the oligo method and the BAC cloning method, and finds that the FISH probes prepared by the two methods can basically enter every cell and specifically bind to the HER2 gene. However, compared with the probes prepared by BAC, the FISH probes prepared by the oligo method emit stronger fluorescence, a larger luminous area, and clearer fluorescence boundaries. In short, it is easier to calculate the copy number of the HER2 gene to achieve the purpose of diagnosing breast cancer.
[0043] The beneficial effects of the present invention include:
[0044] 1. Since repeated sequences and non-specific sequences have been eliminated when designing the probe, the fluorescent in situ hybridization probe prepared by the present invention has high specificity, bright and clear signal points when used, low background and clear without clutter, and higher detection accuracy than the original BAC clone probe, and no need to add Cot 1DNA for blocking;
[0045] 2. The preparation method of the HER2 gene amplification probe provided by the present invention is not limited by BAC cloning and only requires chemical synthesis once, which not only reduces the cost of synthesis, but also reduces the batch difference caused by repeated synthesis;
[0046] 3. The constructed oligonucleotide probe template library is easy to store and can be preserved for a long time; the process for preparing the probe is simple, and a large number of probes can be prepared in a short time, which is suitable for large-scale production;
[0047] 4. The probes prepared by the commonly used bacterial artificial chromosome BAC cloning and polymerase chain reaction PCR (random primer method) are all random in size and uncontrollable, and are generally between 100-1,500 bp in length. The FISH probes prepared by the present invention are uniformly controllable in size, and are between 60-240 bp in size. The shorter the nucleotide sequence, the stronger the penetrating ability, and it can penetrate the cell nuclear membrane more easily, thereby improving the hybridization efficiency, and the higher the fluorescence signal intensity under the fluorescence microscope;
[0048] 5. In addition to screening the primer sequences, the present invention also optimizes the DNA polymerase, probe dye and its concentration of the amplified oligonucleotide to select the most suitable FISH probe preparation scheme for detecting HER2 gene amplification. The prepared fluorescent hybridization probe has a stronger signal under a fluorescent microscope, is easy to observe, and has a stable effect in repeated tests, which is suitable for long-term production of a large number of probes.
[0049] 6. The probe provided by the present invention can be used for in vitro qualitative detection of the copy number of HER2 gene in 10% neutral formalin-fixed paraffin-embedded breast cancer tissue sections, thereby achieving the purpose of rapid and accurate diagnosis of breast cancer.
[0050] 7. The present invention utilizes advanced technology to optimize the production process, thereby reducing product costs and improving product market competitiveness. BRIEF DESCRIPTION OF THE DRAWINGS
[0051] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0052] Figure 1 :Flow chart of the preparation of fluorescent in situ hybridization probes for detecting HER2 gene amplification;
[0053] Figure 2 :Schematic diagram of searching HER2 gene in human genome browser
[0054] Figure 3 :Schematic diagram of searching CEN17 region in human genome browser
[0055] Figure 4 :Schematic diagram of the target area of HER2 gene and CEN17 probe
[0056] Figure 5 :Detection effect of FISH probe prepared by oligo method (repeat 1)
[0057] Figure 6 :Detection effect of FISH probe prepared by oligo method (repeat 2)
[0058] Figure 7 :The detection effect of FISH probe prepared by BAC cloning method (repeat 1)
[0059] Figure 8 :The detection effect of FISH probe prepared by BAC cloning method (repeat 2)
[0060] Fig. 9 : Detection effect of FISH probe labeled with fluorescent dye combination A in Example 7
[0061] Fig.10 : Detection effect of FISH probe labeled with fluorescent dye combination B in Example 7
[0062] Fig.11 : Detection effect of FISH probe labeled with fluorescent dye combination C in Example 7
[0063] Fig.12 : Detection effect of FISH probe labeled with fluorescent dye combination D in Example 7
[0064] Fig.13 : Detection effect of FISH probe labeled with fluorescent dye combination E in Example 7
[0065] Fig.14 : Detection effect of FISH probe labeled with fluorescent dye combination F in Example 7
[0066] Fig.15 : Detection effect of FISH probe labeled with fluorescent dye system 1 in Example 7
[0067] Fig.16 : Detection effect of FISH probe labeled with fluorescent dye system 2 in Example 7
[0068] Fig.17 : Detection effect of FISH probe labeled with fluorescent dye system 3 in Example 7
[0069] Fig.18 : Detection effect of FISH probe labeled with fluorescent dye system 4 in Example 7
[0070] Fig.19 : Detection effect of FISH probe labeled with labeled mixture 1-enzyme-K in Example 8 (repeat 1)
[0071] Fig. 20 : Detection effect of FISH probe labeled with labeled mixture 1-enzyme-K in Example 8 (repeat 2)
[0072] Fig.21: Detection effect of FISH probe labeled with labeled mixture 1-enzyme-K in Example 8 (repeat 3)
[0073] Fig. 22 : Detection effect of FISH probe labeled with labeled mixture 2-enzyme-T in Example 8 (repeat 1)
[0074] Fig.23 : Detection effect of FISH probe labeled with labeled mixture 2-enzyme-T in Example 8 (repeat 2)
[0075] Fig.24 : Detection effect of FISH probe labeled with labeled mixture 2-enzyme-T in Example 8 (repeat 3)
[0076] Fig.25 : Detection effect of FISH probe labeled with 3-enzyme-N in the labeled mixture in Example 8 (repeat 1)
[0077] Fig.26 : Detection effect of FISH probe labeled with 3-enzyme-N in the labeled mixture in Example 8 (repeat 2)
[0078] Fig. 27 : Detection effect of FISH probe labeled with 3-enzyme-N in the labeled mixture in Example 8 (repeat 3) DETAILED DESCRIPTION
[0079] The present invention is further described in detail below in conjunction with the accompanying drawings and specific examples of the specification. The examples are only used to explain the present invention and are not used to limit the scope of the present invention. The test methods used in the following examples are conventional methods unless otherwise specified; the materials and reagents used are reagents and materials that can be obtained from commercial channels unless otherwise specified.
[0080] The fluorescent in situ hybridization probe for detecting HER2 gene amplification provided in this aspect requires CEN17 as an internal control. The preparation steps of the FISH probe are as follows: Figure 1): The sequences of HER2 gene and CEN17 region were searched in the human genome browser (UCSC Genome Browser, http: / / genome.ucsc.edu), and the target region of HER2 gene probe included the coding region of HER2 gene and the non-coding regions at the 5' end and 3' end; the repetitive sequences in the target region of HER2 gene / CEN17 region probe were screened and deleted by molecular bioinformatics technology; the oligonucleotide sequence of the probe target region with a length of 60-240 bp and targeting the HER2 gene / CEN17 region was designed, and then the same adapter was added to both ends of each oligonucleotide for subsequent amplification; then the oligonucleotide pool was constructed by chemical synthesis; the oligonucleotide pool was used as a template, and oligonucleotide probes of the same size were obtained after two PCR amplifications, and the first amplification was amplified with forward and reverse primers without fluorescent labels to obtain a multi-copy probe library targeting the HER2 gene / CEN17 region, and the primer sequence of this amplification was consistent with the above adapter sequence; the primer sequence of the second amplification was the same as that of the first amplification, but contained a fluorescent label, and the purpose was to obtain a single-use fluorescent in situ hybridization probe. The detailed steps for preparing FISH probes for detecting HER2 gene amplification are shown in Examples 1 to 3.
[0081] Example 1: Design of probe for detecting HER2 gene amplification and construction of oligonucleotide library
[0082] 1. Determine the region where the probe targets the HER2 gene and CEN17 locus: Find the HER2 gene / CEN17 interval ( Figure 2 and Figure 3 ), according to the human reference genome (GRCh38.p14 version) data ( Figure 2 ), the HER2 gene is located on p11 of human chromosome 17, with an interval range of 39,684,037–39,732,715 and a serial number of NC_000017.11; according to Figure 3 It was shown that the CEN17 site was located in the centromeric region of human chromosome 17; based on the coding region of the HER2 gene and the non-coding regions at the 5' and 3' ends, the sequence of the target region of the HER2 gene probe was obtained. Figure 4 The target region of the HER2 gene probe is shown in the figure starting from BV105677 (STS site) at the 5' end of the gene to RH75294 (STS site) at the 3' end of the gene, covering an area of approximately 400 kb.
[0083] 2. Delete the repetitive sequences in the probe target region: Use the browser's built-in bioinformatics analysis function - repetitive sequence identification function to mark the repetitive sequences and copy the specific sequences of the non-repetitive sequences in the probe target region to file processing software, such as "Word" or "Excel";
[0084] 3. Design and synthesize oligonucleotide sequences: According to the length of the oligonucleotides to be synthesized, such as 60-240 bp, use the online FASTA mode converter (http: / / avermitilis.ls.kitasato-u.ac.jp / readseq.cgi) to perform mode conversion, and then add the same forward and reverse adapter sequences to both ends of each oligonucleotide, and perform chemical synthesis. This embodiment provides 15 pairs of adapter sequences (primers are shown in Table 1), and one pair can be selected, and primer pair 11 (SEQ ID NO: 21 and SEQ ID NO: 22) is preferably selected; finally, a pool of oligonucleotides targeting the HER2 gene / CEN17 interval with uniform size is obtained (the region or sequence targeted by each oligonucleotide in the oligonucleotide pool is shown in Table 2 and Table 3). As shown in Table 2 and Table 3, the constructed oligonucleotide library targeting the target region of the HER2 gene / CEN17 interval contains 4,277 and 17 nucleotide fragments (excluding adapters), respectively, with a length of 101 bp.
[0085] Table 1 Linker sequences
[0086] Primer pairs Forward primer Serial Number Reverse primer Serial Number 1 5'-CGCACCAGCGTATTCGTGTC-3' SEQ ID NO:1 5'-AGTATGGTGCTCCGTGTTCG-3' SEQ ID NO:2 2 5'-AACCAGGCGGGCTCGCCACG-3' SEQ ID NO:3 5'-AAGCGCGTTGCTACCTAGAC-3' SEQ ID NO:4 3 5'-TTCGATTGTCGTGGCCACCC-3' SEQ ID NO:5 5'-AGTGAGCTGCGAGAGCTTTG-3' SEQ ID NO:6 4 5'-AGTTAACATGTAGCCCGGCC-3' SEQ ID NO:7 5'-CGTCGGTACCACGTATCGGG-3' SEQ ID NO:8 5 5'-ATCTAGGAGGGGCGCGTAGG-3' SEQ ID NO:9 5'-GGGCATCCTGTCACAAGGAG-3' SEQ ID NO:10 6 5'-ACCCCAATCGTTTTCCGTCG-3' SEQ ID NO:11 5'-CTGTCAAGGGATTCCCGTGG-3' SEQ ID NO:12 7 5'-GGGCAATACGAGCTCAAGCC-3' SEQ ID NO:13 5'-ACTCAGCGTCGCTCCCATTG-3' SEQ ID NO:14 8 5'-AAGCGGACAGCGGTTCTACG-3' SEQ ID NO:15 5'-ACCCCGGTCCGTTCTGAGTC-3' SEQ ID NO:16 9 5'-GGCCACGCGTCGACTAGTAC-3' SEQ ID NO:17 5'-AACTTGTATCCGACCCCCGC-3' SEQ ID NO:18 10 5'-CCCGGCGCAGAGAGGAAGCC-3' SEQ ID NO:19 5'-CGAGTGTCACGTCTGACCTC-3' SEQ ID NO:20 11 5'-GCTGTAGCAGCAGGCTGTGC-3' SEQ ID NO:21 5'-AGCCAAAAAAGCACGTGGTG-3' SEQ ID NO:22 12 5'-CACCCGGGGGATGTCTAAAC-3' SEQ ID NO:23 5'-TATGGCACTCATCCCAGCTG-3' SEQ ID NO:24 13 5'-GGTGCCTGGTTTCACTACCC-3' SEQ ID NO:25 5′-TAACGGAGAGACCCTGCGGC-3′ SEQ ID NO:26 14 5'-GAGCCTAGGTCCACTGGAGG-3' SEQ ID NO:27 5'-CAGGGTTTTCCCAGTCACGAC-3' SEQ ID NO:28 15 5'-GGCTCTGCGACCCGTTCCGG-3' SEQ ID NO:29 5'-ATGGTCCTGCTGGAGTTCGTG-3' SEQ ID NO:30
[0087] Table 2 Oligonucleotide library targeting the HER2 gene target region
[0088]
[0089]
[0090]
[0091]
[0092]
[0093]
[0094]
[0095]
[0096]
[0097]
[0098]
[0099] Table 3 Oligonucleotide sequences targeting CEN17 region
[0100]
[0101] Example 2: Construction of a probe template library for detecting HER2 gene amplification
[0102] 1. According to the synthesis report of the oligonucleotide library, the oligonucleotide pool described in Example 1 was diluted and packaged, and 1 μL of the above oligonucleotide library dilution was taken and its concentration was detected by a micro-spectrophotometer.
[0103] 2. Construction of probe template library: Use any pair of specific amplification primers in Table 1, preferably primer pair 11 (SEQ ID NO: 21 and SEQ ID NO: 22); use the above oligonucleotide library as a template, amplify by PCR reaction, thereby obtaining a large number of oligonucleotides, and completing the construction of oligonucleotide library-probe template library. The amplification system is shown in Table 4, wherein the DNA polymerase is a high-fidelity DNA polymerase (Phanta ax Super-Fidelity DNA Polymerase, Vazyme), and the amplification program is shown in Table 5.
[0104] Table 4 PCR amplification system
[0105] Components Final concentration BUFFER(GC) / <![CDATA[MgCl2]]> 2.5mM dNTP 0.3mM Forward Primer F 2μM Reverse primer R 2μM DNA polymerase 0.02U Template DNA 2ng / μL
[0106] Table 5 PCR amplification program
[0107]
[0108] 3. Purification of probe template library: The probe template library is purified by gel microcolumn centrifugation, that is, the molecular sieve effect of the gel and the centrifugation method are used to separate macromolecular DNA and small molecular dNTP and other substances. The gel microcolumn medium used in this embodiment is Sephadex G-50. 800 μL of Sephadex G50 is added to the sterilized purification column, and centrifuged at a speed of 1,100 rcf for 4 minutes; 500 μL of 1×TES is added to the purification column, and centrifuged at a speed of 1,100 rcf for 4 minutes; the above pretreated purification column is placed in a clean 50 mL centrifuge tube; all the PCR reaction solution in step 2 is taken out, and the tube wall cannot be touched during absorption, and then the sample is added to the center of the column mattress, and the sample cannot be added to the gap between the mattress and the tube wall; centrifuged at a speed of 2,200 rcf for 6 minutes, and the purification column is discarded. The filtrate is the probe template library for detecting HER2 gene amplification.
[0109] Example 3: Preparation of a dual-color fluorescent probe for detecting HER2 gene amplification
[0110] 1. Labeling probe: Add labeling mixture (containing the enzyme used for labeling - KAPA HiFi enzyme, manufacturer: Roche Diagnostics Products (Shanghai) Co., Ltd.), primer mixture (primer sequence is the linker sequence described in Example 2 and contains fluorescent dyes ATTO-1 (manufacturer: Shanghai Jierui Bioengineering Co., Ltd.) and Fluorescein (manufacturer: Shanghai Jierui Bioengineering Co., Ltd.)), probe template library (oligo template) and purified water (see Table 6) to a sterilized clean PCR tube in sequence, label the HER2 probe with green fluorescence, and label the CEN17 probe with orange fluorescence; flick the test tube by hand to mix, cover the tube cap, and centrifuge briefly to remove liquid from the tube wall; put the above reaction system into a thermal cycler, cover the thermal cycler, set the top cover temperature to 104°C, set the thermal cycler reaction program (see Table 7), and run the program; after the program is completed, take out the reaction solution and place it in an ice box.
[0111] Table 6 Oligo probe labeling system
[0112]
[0113] Table 7 Labeling reaction procedure
[0114]
[0115] 2. Purify the fluorescent probe: add 0.8mL of Sephadex G50 soaking solution to a sterilized clean centrifuge column, centrifuge at 1,100rcf for 4min at 4℃, and discard the waste liquid at the bottom of the column; add 0.5mL of 1×TES to the centrifuge column, centrifuge at 1100rcf for 4min at 4℃, and discard the waste liquid at the bottom of the column; put the pretreated centrifuge column on a sterilized clean 1.5mL centrifuge tube; add the PCR reaction solution in step 1 to the center of the centrifuge column mattress; centrifuge at 2,200rcf for 10min at 4℃, collect the filtrate, and combine all the filtrates into the same centrifuge tube. The filtrate obtained is the purified fluorescent probe. The obtained probe is the probe intermediate; and its concentration is detected: CEN17 probe intermediate: 160.85ng / μL; HER2 probe intermediate: 170.1ng / μL.
[0116] 3. Concentrated fluorescent probes: Add 75 ng / person of each of the two probes purified in step 2 into a concentrating centrifuge tube (manufacturer: Corning); add an appropriate amount of hybridization solution (10 μL / person), wherein the hybridization solution comprises 2×SSC buffer, 30-60% formamide and 1 g-3 g / 10 mL of dextran sulfate; after centrifugation, place in a 37°C water bath to dissolve for 60 minutes, mixing every 5 minutes during the period, to obtain concentrated fluorescent probes.
[0117] 4. Dispense probes and staining solutions: Use a pipette to dispense HER2-CEN17 dual-color probes or staining solutions into natural-color cryopreservation tubes and cover them with red cryopreservation tube caps. After dispensing, you will get the required probes or staining solutions. See Tables 8 and 9 for specific amounts.
[0118] Table 8 HER2-CEN17 probe loading table
[0119]
[0120] Table 9 Dyeing liquid filling table
[0121]
[0122] Example 4: Method for using a dual-color fluorescent probe to detect HER2 gene amplification
[0123] 1. Sample processing: Place laboratory cultured lymphocytes in a centrifuge tube containing 10 mL of hypotonic solution preheated at 37°C, and mix by gently pipetting; incubate in a 37°C water bath for 30 min; add 1 mL of fresh fixative, mix by gently pipetting, and pre-fix at room temperature for 8 minutes; mix by pipetting, and centrifuge at 1,500 rpm for 8 minutes; remove the supernatant, add 10 mL of fresh fixative to the precipitate, mix by gently pipetting, let stand at room temperature for 8 minutes, and centrifuge at 1,500 rpm for 8 minutes; repeat the above washing steps until the cell precipitate is clean.
[0124] 2. Preparation: Take a clean glass slide; after resuspending the cells, take 3μL of the suspension and drop it on different positions on the glass slide, being careful not to overlap; let it dry at room temperature; use a 20× objective lens to observe the cell density of the three areas under a phase contrast microscope, requiring that there is no obvious overlap of cells and the number should be between 100 and 200; if the cells overlap, add an appropriate amount of fresh fixative to dilute the cell suspension, mix well and take another 3μL of the cell suspension for preparation; if the cell density is low, centrifuge, carefully remove an appropriate amount of supernatant, mix well and take another 3μL of the suspension for preparation, dry and observe; observe under a phase contrast microscope. If there are too many cell fragments, pretreatment is required and a suitable hybridization area should be selected; at least one more slide should be prepared for each sample, and the remaining cell suspension can be stored at 2-8°C for one month so that it can be re-prepared when necessary.
[0125] 3. Preheat the washing solution: Turn on the thermostatic water bath and set the temperature to 37°C. Pour 50mL of enzyme buffer into the Coplin jar, put it into the water bath, and preheat it to 37°C; before elution, set the thermostatic water bath temperature to 68°C, pour the washing solution into the Coplin jar, and put it into the water bath for at least 30 minutes, ensuring that the temperature of the washing solution reaches 68°C ± 1°C before use.
[0126] 4. Pre-treat the sample: Soak the slide prepared in step 2 in 2×SSC solution at room temperature for 10 minutes; digest in pepsin solution at 37±1℃ for 10 minutes; soak the slide in 2×SSC solution at room temperature for 2 minutes; dehydrate the slide by soaking in 70%, 85%, and 100% alcohol solutions for 1 minute each; air-dry the slide at room temperature.
[0127] 5. Sample denaturation and hybridization: soak the moisturizing strip in pure water and place it in the corresponding slot of the hybridizer, making sure the surface of the hybridizer is clean and free of objects; set the denaturation and hybridization program: denaturation: 85°C, 4 minutes, hybridization: 43°C, 16-18 hours; take out the probe, put it at room temperature, vortex centrifuge, take 10μL of the probe, and drop it on the target area of the slide; cover with a coverslip, be careful to avoid bubbles, and seal the edge of the coverslip with sealing glue; place the sealed slide on the hybridizer and start the denaturation and hybridization program.
[0128] 6. Post-hybridization treatment: preheat solution 1 (JLB101001-in situ hybridization sample pretreatment reagent, Jinlu reagent) according to the method in step 3, and keep solution 2 at room temperature; after hybridization, take out the cell slide, remove the sealing glue and cover glass from the cell slide; put the slide into solution 1 at 68±1℃, soak and rinse for 2 minutes; put the slide into solution 2 at room temperature, soak for 1 minute; put the slide in 70% alcohol solution and wash for 1 minute; take out the slide and dry it naturally in the dark.
[0129] 7. Re-staining: Add 10 μL of homemade staining solution to the hybridization area, avoid bubbles, cover with a coverslip, carefully remove excess staining solution with absorbent paper, place at -20℃±5℃, and re-stain in a dark place for more than 20 minutes.
[0130] 8. Observation results: Select the appropriate filter set to observe the results under a fluorescence microscope, find the area under the 10× objective lens, and count under the 100× objective lens; adjust the focus and find the appropriate area, which requires the cell nucleus boundary to be complete, the staining solution to be evenly stained, the nucleus to have no overlap, and the signal points to be clear; in the selected area, find all signal points at different levels of the nucleus, count the fusion signal, separate orange signal, and green signal; when the orange-red and green signal points overlap or the distance between them is less than the diameter of one signal point, it is counted as one fusion signal (yellow fluorescence); cell nuclei with no signal or weak signal are not counted.
[0131] Example 5: Preparation of a dual-color fluorescent probe for detecting HER2 gene amplification using BAC cloning
[0132] In order to compare the detection effects of the probes prepared by the oligo method and the BAC cloning method provided by the present invention, this example uses BAC cloning to prepare a fluorescent probe for detecting HER2 gene amplification, and the specific steps are as follows:
[0133] 1. Extraction of BAC clones containing HER2 gene and CEN17 region: Inoculate the BAC monoclonal clone containing HER2 gene and CEN17 region into a sterile 50 mL centrifuge tube containing 15 mL LB liquid culture medium containing chloramphenicol, and culture overnight at 37°C with a shaker at 220 rpm; use QIAprep Spin Miniprep Kit (250) (Qiagen) plasmid miniprep kit to extract the plasmid from the overnight culture solution, and use Qubit3 nucleic acid protein quantifier (Thermo) to detect the plasmid concentration. The specific results are shown in Table 10.
[0134] 2. Enzyme digestion of BAC plasmid: The enzyme digestion system is: 1 μL BAC plasmid, 2 μL EcoRⅠ enzyme, 1 μL 10×EcoRⅠ buffer and 6 μL purified water, and the enzyme digestion system is placed in a 37°C water bath for 60 minutes.
[0135] Table 10 BAC plasmid concentration
[0136]
[0137] 3. Amplify BAC cloning template: Take the BAC plasmid after enzyme digestion in step 2 as the template to construct an amplification system with a total system volume of 10 μL. The components and volumes are shown in Table 11. Tap the tube wall to mix, and centrifuge briefly; set the temperature of the PCR instrument to 95°C, denature for 3 minutes, quickly insert into ice, tap the tube wall after cooling, and centrifuge briefly; add the sample to Ready-To-Go GenomiphiV3 cake (Manufacturer: Qiagen Enterprise Management (Shanghai) Co., Ltd.), cover the lid, incubate at 30°C in the PCR instrument for 120 minutes, and then at 65°C for 10 minutes; dilute the above reaction solution 10 times, tap the tube wall, centrifuge briefly, and detect its concentration using Qubit3.0 nucleic acid protein quantifier. The specific results are shown in Table 12.
[0138] Table 11 Amplification system
[0139]
[0140] Table 12 DNA concentration after amplification (10-fold dilution)
[0141]
[0142] 4. Purify template DNA: add 1 / 10 volume of 3.0M sodium acetate and 2.5 times volume of anhydrous ethanol to the template DNA, mix well, centrifuge briefly, and let stand on ice for 30 minutes; centrifuge at 15,000rpm, 4°C for 15 minutes, discard the supernatant, add 500μL pre-cooled 70% anhydrous ethanol, mix well, centrifuge at 15,000rpm, 4°C for 5 minutes, discard the supernatant, centrifuge briefly, and aspirate the remaining supernatant; let it stand at room temperature for several minutes until the alcohol is evaporated, add an appropriate amount of purified water (the volume of water added is shown in Table 13), dissolve at 4°C overnight, the resulting solution is the probe, and the probe concentration is measured using Qubit3.0 nucleic acid protein quantifier. The results are shown in Table 13.
[0143] Table 13 Probe concentration
[0144]
[0145] 5. Labeling probe: Divide the labeling reaction mixture (see Table 14) into 0.5 mL centrifuge tubes, with no more than 50 μL in each tube, and centrifuge until there is no liquid on the tube wall; transfer the centrifuge tube containing the labeling reaction mixture to a thermal cycler and react at 15°C for 16 hours; denature at 70°C in the thermal cycler for 10 minutes, cool immediately, then centrifuge until there is no liquid on the tube wall, and place in an ice box.
[0146] Table 14 BAC probe labeling system
[0147]
[0148] 6. Purify the probe: as described in Example 3.
[0149] Example 6: Comparison of detection effects of probes prepared by oligo method and BAC cloning method
[0150] This example compares the detection effects of probes prepared by the oligo method and the BAC cloning method. The steps of preparing the probes by the oligo method are the same as those described in Examples 1 to 3, the preparation process of the BAC cloning method is the same as that described in Example 5, and the methods of using the probes prepared by the two methods are the same as those described in Example 4. Each experimental group is repeated twice. The specific detection effects are shown in Figures 5 to 8 .
[0151] Depend on Figures 5 to 8 It can be seen that the FISH probes prepared by the oligo method and the BAC cloning method can basically enter every cell and bind specifically to the HER2 gene or CEN17 site, but compared with the probes prepared by BAC ( Figure 7-Figure 8 ), FISH probes prepared by oligo method ( Figure 5-6) has a stronger fluorescence intensity, a larger luminous area, a clearer fluorescence boundary, and fewer spots in the internal control CEN17. In short, it is easier and more accurate to detect whether the HER2 gene copy number has increased. In addition, the oligo preparation method is not limited by the number of BAC clones, so the oligo method is more suitable for preparing FISH probes for detecting HER2 gene amplification.
[0152] Example 7: Optimization of the type and amount of fluorescent dye
[0153] The fluorescent dyes used in the probe fluorescent labeling step in Example 3 are ATTO-1 and Fluorescein. In this example, the fluorescent dyes used to label the probes are first optimized. The types and combinations of the dyes used are shown in Tables 15 and 16. Different fluorescent dyes are mixed in a volume ratio of 1:1. The specific steps for labeling the probes with other fluorescent dyes are as described in Example 3, and the fluorescent in situ hybridization experimental steps are as described in Example 4. The detection effects of probes labeled with different dye combinations are shown in Figures 9 to 14 .
[0154] Table 15 Types of fluorescent dyes
[0155] Dye Name Material Information Orange dye ATTO-1 Orange Dye 1 ATTO-2 Orange Dye 2 TERMA Green Dye 1 Fluorescein Green Dye 2 Alexa
[0156] Table 16 Combinations of fluorescent dyes
[0157] Orange dye Orange Dye 1 Orange Dye 2 Green Dye 1 A C E Green Dye 2 B D F
[0158] By comparing the combination A( Fig. 9 ) and B( Fig.10 )、Combination C( Fig.11 ) and D( Fig.12 ) and combination E( Fig.13 ) and F( Fig.14 ) It can be seen that the fluorescence emitted by the probe labeled with green dye 1 is stronger, the luminescent area is larger, and the fluorescence boundary is clearer; similarly, according to the fluorescence intensity and background cleanliness, it can be seen that the orange-red dye has the best labeling effect, followed by orange dye 1. In summary, the best fluorescent dye combination is dye combination A (orange-red dye ATTO-1 and green dye 1 Fluorescein).
[0159] This example uses the above combination A to explore the effect of dye dosage on the detection effect of fluorescent probes. The specific system is shown in Table 17, and the labeling and FISH experimental process is shown in Examples 3 and 4. The detection effect of probes labeled with different dye dosages is shown in Figure 15 to Figure 18 .
[0160] Table 17 Fluorescent dye system for labeled probes
[0161] system System 1 System 2 System 3 System 4 ATTO-1 / mM 0.01 0.02 0.05 0.1 Fluorescein / mM 0.01 0.02 0.05 0.1
[0162] According to the above criteria for judging the detection effect of the probe, i.e., fluorescence intensity, fluorescence area and area boundary, background noise and other parameters, it can be considered that the optimal concentration ranges of the orange-red dye and the green dye 1 are 0.01-0.1 mM and 0.01-0.1 mM, respectively, and the best concentrations are 0.01 mM and 0.05 mM, respectively.
[0163] Example 8: Optimization of enzymes for amplifying fluorescent probes
[0164] This example uses different high-fidelity enzymes to amplify the probe, and uses FISH experiments to test the final effect of amplification by different enzymes. Different labeling mixtures 1 to 3 contain different enzymes, respectively using enzyme K: KAPA HiFi enzyme (Roche Diagnostics), enzyme T: TIANSeq HiFi Amplification Mi (TIANGEN), enzyme N: Phantaax Super-FidelityDNA Polymerase (Nuoweizan), each experimental group is repeated three times, the specific labeling system is shown in Table 18, and the specific labeling steps and FISH experimental process are shown in Examples 3 and 4.
[0165] Table 18 Amplification system
[0166]
[0167] By observation Figure 19 to Figure 27 From the fluorescence intensity, fluorescence area and area boundary, background noise, etc., it can be seen that the type of DNA polymerase used to amplify the probe has little effect on the detection effect of the fluorescent probe, that is, the above three enzymes (enzyme-K, enzyme-T and enzyme-N) can all be used to amplify the FISH probe for detecting HER2 gene amplification, but enzyme N (Phanta ax Super-Fidelity DNA Polymerase) is the best.
[0168] Example 9: Optimization of linker sequence
[0169] In the initial screening, the four pairs of primers, such as the forward primer shown in SEQ ID NO: 17 and the reverse primer sequence shown in SEQ ID NO: 18 (corresponding to primer pair 9 in Table 1), the forward primer shown in SEQ ID NO: 19 and the reverse primer sequence shown in SEQ ID NO: 20 (corresponding to primer pair 10 in Table 1), the forward primer shown in SEQ ID NO: 21 and the reverse primer sequence shown in SEQ ID NO: 22 (corresponding to primer pair 11 in Table 1), and the forward primer shown in SEQ ID NO: 25 and the reverse primer sequence shown in SEQ ID NO: 26 (corresponding to primer pair 13 in Table 1), had good amplification effects.
[0170] Therefore, in this example, the above four pairs of primers are used in the design and synthesis of oligo probes. The specific design and preparation of oligo probes refer to Examples 1 to 3. The prepared probes are used in the manner of Example 4 to detect the copy number of the HER2 gene in cells.
[0171] Table 19 Effect of different adapter primers on hybridization efficiency
[0172] Primer pair 9 Primer pair 10 Primer pair 11 Primer pair 13 91% 86% 98% 88%
[0173] According to the test results, the hybridization efficiency (the ability of the probe in the reagent to bind to the target sequence) after the above primer pairs were calculated respectively. The calculation method of the hybridization efficiency was normal signal count cells / counted cells. The results are shown in Table 19. The hybridization efficiency of different primer pairs was different. It may be that during the hybridization process, dimers were formed between the probes or between the probes and the gene target sites, resulting in spatial binding hindrance. Primer pair 11 had the highest hybridization efficiency and excellent signal intensity, so primer pair 11 was preferred.
[0174] The embodiments described above provide a detailed description of the technical solutions of the present invention. It should be understood that the above are only specific embodiments of the present invention and are not intended to limit the present invention. Any modifications, supplements or similar substitutions made within the scope of the principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for preparing a novel FISH probe for detecting HER2 gene amplification, characterized in that: The preparation method belongs to the oligo probe preparation method, which comprises the following steps: (1) determining the probe target region of the HER2 gene and the CEN17 locus and removing repeated nucleotide sequences in the probe target region, wherein the HER2 gene probe target region includes the coding region of the HER2 gene and the non-coding regions at the 5' end and the 3' end; (2) designing and chemically synthesizing oligonucleotide fragments of uniform length according to the HER2 gene / CEN17 locus probe target region, wherein the oligonucleotide sequence length is 60 to 240 bp; the oligonucleotide fragments comprise a linker and a fragment that specifically binds to the HER2 gene / CEN17 locus probe target region; and the oligonucleotide sequences constitute an oligonucleotide library; (3) Using the oligonucleotide library in step (2) as a template and the linker sequence in step (2) as a primer, PCR amplification is performed to obtain a probe template library; using the probe template library as a template, forward and reverse primers containing fluorescent markers are used to perform PCR amplification to obtain an in situ hybridization fluorescent probe for detecting HER2 gene amplification using CEN17 as an internal control, wherein the forward and reverse primer sequences are the same as the linker sequence.
2. The method according to claim 1, characterized in that The adapter sequence designed in step (2) and the primers used to amplify the probe template library in step (3) are the forward primer shown in SEQ ID NO:1 and the reverse primer shown in SEQ ID NO:2, the forward primer shown in SEQ ID NO:3 and the reverse primer shown in SEQ ID NO:4, the forward primer shown in SEQ ID NO:5 and the reverse primer shown in SEQ ID NO:6, the forward primer shown in SEQ ID NO:7 and the reverse primer shown in SEQ ID NO:8, the forward primer shown in SEQ ID NO:9 and the reverse primer shown in SEQ ID NO:10, the forward primer shown in SEQ ID NO:11 and the reverse primer shown in SEQ ID NO:12, the forward primer shown in SEQ ID NO:13 and the reverse primer shown in SEQ ID NO:14, the forward primer shown in SEQ ID NO:15 and the reverse primer shown in SEQ ID NO:16, the forward primer shown in SEQ ID NO:17 and the reverse primer shown in SEQ ID NO:18, the forward primer shown in SEQ ID NO:19 and the reverse primer shown in SEQ ID NO:20, and the forward primer shown in SEQ ID NO:
21. The forward primer shown in NO:21 and the reverse primer shown in SEQ ID NO:22, the forward primer shown in SEQ ID NO:23 and the reverse primer shown in SEQ ID NO:24, the forward primer shown in SEQ ID NO:25 and the reverse primer shown in SEQ ID NO:26, the forward primer shown in SEQ ID NO:27 and the reverse primer shown in SEQ ID NO:28, the forward primer shown in SEQ ID NO:29 and the reverse primer shown in SEQ ID NO:30, at least one pair among the above 15 primer pairs.
3. The method according to claim 2, characterized in that The linker sequence designed in step (2) and the primers used to amplify the probe template library in step (3) are the forward primer shown in SEQ ID NO: 21 and the reverse primer shown in SEQ ID:
22.
4. The method according to claim 1, characterized in that The DNA polymerase used in PCR amplification in step (3) is Phantaax Super-Fidelity DNA Polymerase.
5. The method according to claim 1, characterized in that: The repeating sequence in step (1) comprises an oligonucleotide sequence of TTTT and AAAA; the oligonucleotide sequence in step (2) is 121 bp.
6. The method according to claim 1, characterized in that In step (3), the probe targeting the HER2 gene region is labeled with the green fluorescent dye Fluorescein, while the probe targeting the CEN17 region is labeled with the orange fluorescent dye ATTO-1.
7. The method according to claim 1, characterized in that The concentration ranges of the fluorescent dyes Fluorescein and ATTO-1 are 0.005-0.1 mM and 0.005-0.1 mM respectively.
8. A novel FISH probe for detecting HER2 gene amplification, characterized in that: Prepared by the method according to any one of claims 1 to 7, the FISH probe further comprises a hybridization solution and a staining solution.
9. A use of a specific amplification primer to improve the post-probe fluorescence effect obtained in the preparation of a fluorescent in situ hybridization probe for detecting HER2 gene amplification, wherein the sequence of the specific amplification primer pair is a forward primer shown in SEQ ID NO: 21 and a reverse primer shown in SEQ ID NO:
22.
10. Use of an oligo method in the preparation of fluorescent in situ hybridization probes for detecting HER2 gene amplification to improve the post-target fluorescence effect of the obtained probe.
